2003
DOI: 10.1017/s0033291703007645
|View full text |Cite
|
Sign up to set email alerts
|

Antidepressants for the treatment of depression in people with schizophrenia: a systematic review

Abstract: The literature reviewed was, overall, of poor quality and only a small number of trials could contribute towards the meta-analysis. The results provide weak evidence for the effectiveness of antidepressants in those with schizophrenia and depression and could be explained by publication bias. We need further research to determine the best approach towards treating depression in people with schizophrenia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
38
0
4

Year Published

2005
2005
2016
2016

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 87 publications
(47 citation statements)
references
References 26 publications
(51 reference statements)
1
38
0
4
Order By: Relevance
“…For example, if seen as an inherent part of the psychosis symptom profile, depression might be expected to respond to antipsychotic drugs, whereas if the clinician perceives a 'superimposed' depressive episode, antidepressants might appear appropriate. The most common treatment approach reported by respondents of the survey was augmenting neuroleptics with antidepressant medications, a practice for which empirical support is weak (Whitehead, Moss, Cardno, & Lewis, 2003;Micallef, Fakra, & Blin, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…For example, if seen as an inherent part of the psychosis symptom profile, depression might be expected to respond to antipsychotic drugs, whereas if the clinician perceives a 'superimposed' depressive episode, antidepressants might appear appropriate. The most common treatment approach reported by respondents of the survey was augmenting neuroleptics with antidepressant medications, a practice for which empirical support is weak (Whitehead, Moss, Cardno, & Lewis, 2003;Micallef, Fakra, & Blin, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Bu bilgilere rağmen, şizofreni hastalarında depresyon ihmal edilerek yeterli biçimde tedavi edilmemekte ve bu da özkıyım davranışına yol açmaktadır. Psikotik semptomları artırmadan antidepresanların etkin bir şekilde kullanılabileceği gösterilmişse de, hâlâ şizofreni hastalarında kullanımları beklenenin altındadır (57). Depresyon sıklıkla ilaç yan etkileri ve negatif semptomlarla maskelenir ve karışırken, dikkatli bir klinisyen belirli hedef sorularla depresyonu saptayabilir.…”
Section: Discussionunclassified
“…Our data suggest that the use of concomitant medications, including antipsychotic polypharmacy, occurs even in the earliest stages of the disease. However, to date, there is only insufficient evidence supporting the use of concomitant medications with antipsychotics, except for the treatment of comorbid major depression (40), and one study found that in most cases non-antipsychotic concomitant medications could be discontinued without any worsening in mental state (41). On the other hand, one meta-analysis found that antidepressants might reduce negative symptoms (42), and an earlier study suggested that antidepressant treatment added to antipsychotics in schizophrenia might reduce relapse rates into psychosis in addition to reducing recurrence of postpsychotic depression (43).…”
Section: Discussionmentioning
confidence: 99%